Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RARE · against 1,372 other Healthcare companies
Ranked #1,235 of 1,373 · scores higher than 10% of peers · safety percentile 10
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 10–19, including RARE · Click a bar to see the companies
Mainly because of its debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RARE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | Not reported | 0.24× | — | — | 33% |
| BetaLower is better · 1,320 reported | 0.32 | 0.53 | 66% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.73× | 2.62× | 33% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,231 | 2.7B CAD (≈$2.0B) | 10 | 54 | |
| 1,232 | 8.4B USD | 10 | 28 | |
| 1,233 | 1.6B USD | 10 | 43 | |
| 1,234 | 365M EUR (≈$401M) | 10 | 44 | |
| 1,235 | 1.6B USD | 10 | 24 | |
| 1,236 | 68.0B BRL (≈$12.2B) | 10 | 67 | |
| 1,237 | 5.7B USD | 10 | 30 | |
| 1,238 | 522M USD | 10 | 12 | |
| 1,239 | 1.2B SGD (≈$945M) | 10 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score